Our research findings are published in international, peer-reviewed journals and feature in conference talks and lectures, as well as in poster presentations and at scientific events.

MLL frequently hosts international research cooperation directly: For
instance through exchange programs, our test procedures and data
repositories, but also by allowing guest researchers to shadow the work
of our facility and by sitting on national and international work

We also support research institutions around the world to
produce new insight in the field of leukemia diagnostics and emergence,
as well as in the rollout of new procedures and applications for routine
diagnostics in the facilities themselves.

Overview of our publications

Diagnostik bei unklaren Zytopenien – wie und wann suchen wir nach klonaler Hämatopoese?

Haferlach C, Heuser M. Die Innere Medizin. 2022.

Read more

Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia

Duncavage EJ, Bagg A, Hasserjian RP, DiNardo CD, Godley LA, Iacobucci I, Jaiswal S, Malcovati L, Vannucchi AM, Patel KP, Arber DA, Arcila ME, Bejar R, Berliner N, Borowitz MJ, Branford S, Brown AL, Cargo CA, Döhner H, Falini B, Garcia-Manero G, Haferlach T, Hellström-Lindberg E, Kim AS, Klco JM, Komrokji RS, Loh ML, Loghavi S, Mullighan CG, Ogawa S, Tefferi A, Papaemmanuil E, Reiter A, Ross DM, Savona MR, Shimamura A, Skoda RC, Sole F, Stone RM, Orazi A, Walter MJ, Wu D, Ebert BL, Cazzola M. Blood. 2022.

Read more

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)

Hehlmann R, Lauseker M, Voskanyan Astghik, Fabarius A, Haferlach C, Hochhaus A, Saußele S. Leukemia. 2022.

Read more

Precision Medicine in Therapy of Non-solid Cancer

Schmidts I, Haferlach T, Hoermann G. Handb Exp Pharmacol. 2022.

Read more

TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype.

Ramos-Campoy S, Puiggros A, Kamaso J, Beà S, Bougeon S, Larráyoz MJ, Costa D, Parker H, Rigolin GM, Blanco ML, Collado R, Ancín I, Salgado R, Moro-García MA, Baumann T, Gimeno E, Moreno C, Salido M, Calvo X, Calasanz MJ, Cuneo A, Nguyen-Khac F, Oscier D, Haferlach C, Strefford JC, Schoumans J, Espinet B. Cancers (Basel). 2022.

Read more

Smiljkovic D, Herrmann H, Sadovnik I, Gamperl S, Berger D, Stefanzl G, Eisenwort G, Hoermann G, Kopanja S, Dorofeeva Y, Focke-Tejkl M, Jaksch P, Hoetzenecker K, Szepfalusi Z, Valenta R, Arock M, Valent P. J Allergy Clin Immunol. 2022.

Expression and Regulation of Siglec-6 (CD327) on Human Mast Cells and Basophils

Read more

Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms

Wang BA, Mehta HM, Penumutchu SR, Tolbert BS, Cheng C, Kimmel M, Haferlach T, Maciejewski JP, Corey SJ. Leukemia. 2022.

Read more

You may also be interested in


Our goal is to provide the best leukemia diagnostics for our patients through a comprehensive set of methods, state-of-the-art equipment and continuous development.

Learn more


Do you have questions about sample submission, analyses performed or findings? Here you will find contact details, contact persons and our most frequently asked questions (FAQs).

Learn more

About us

We believe that exceptional things happen when knowledge, courage and responsibility come together. In a world that offers so many possibilities, our goal is to make the best possible leukemia diagnostics available worldwide and to all patients.

Learn more